Cargando…
High expression of PRKDC promotes breast cancer cell growth via p38 MAPK signaling and is associated with poor survival
BACKGROUND: DNA‐Dependent Protein Kinase Catalytic Subunit (PRKDC), a key component of the DNA damage repair pathway, is associated with chemotherapy resistance and tumor progression. METHODS: Here we analyzed transcriptome data of ~2,000 breast cancer patients and performed functional studies in vi...
Autores principales: | Zhang, Yan, Yang, Wei‐kang, Wen, Guo‐ming, Tang, Hongping, Wu, Chuan‐an, Wu, Yan‐xia, Jing, Zhi‐liang, Tang, Min‐shan, Liu, Guang‐long, Li, Da‐zhou, Li, Yan‐hua, Deng, Yong‐Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825841/ https://www.ncbi.nlm.nih.gov/pubmed/31513357 http://dx.doi.org/10.1002/mgg3.908 |
Ejemplares similares
-
IL-10 and PRKDC polymorphisms are associated with glioma patient survival
por: Hu, Mingjun, et al.
Publicado: (2016) -
Role of PRKDC in cancer initiation, progression, and treatment
por: Chen, Yu, et al.
Publicado: (2021) -
PRKDC: new biomarker and drug target for checkpoint blockade immunotherapy
por: Tan, Kien Thiam, et al.
Publicado: (2020) -
Prevalence of PRKDC mutations and association with response to immune checkpoint inhibitors in solid tumors
por: Chen, Yu, et al.
Publicado: (2020) -
Up‐regulation of PRKDC was associated with poor renal dysfunction after renal transplantation: A multi‐centre analysis
por: Cao, Zhijun, et al.
Publicado: (2023)